These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 35632837)

  • 1. Elimination of Hepatitis C in Southern Italy: A Model of HCV Screening and Linkage to Care among Hospitalized Patients at Different Hospital Divisions.
    Rosato V; Kondili LA; Nevola R; Perillo P; Mastrocinque D; Aghemo A; Claar E
    Viruses; 2022 May; 14(5):. PubMed ID: 35632837
    [No Abstract]   [Full Text] [Related]  

  • 2. A territory-wide opportunistic, hospital-based HCV screening in the general population from northern Italy: The 1969-1989 birth-cohort.
    D'Ambrosio R; Piccinelli S; Beccalli B; Spinetti A; Puoti M; Fagiuoli S; Magni CF; Vavassori A; Sacchi P; Castaldi S; Bombardieri G; Farina C; Buoro S; Amorosi A; Corradin M; Cereda D; Lampertico P;
    Liver Int; 2023 Dec; 43(12):2645-2656. PubMed ID: 37715524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HCV point-of-care screening programme and treatment options for people who use drugs in a metropolitan area of Southern Italy.
    Persico M; Masarone M; Aglitti A; Armenante C; Giordano A; Guardiola A; Raimondi G; Contaldi C; Nigro C; Marena G; De Luna A
    Liver Int; 2019 Oct; 39(10):1845-1851. PubMed ID: 31169953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of test-and-treat model with direct-acting antiviral for hepatitis C virus infection in migrants: a prospective interventional study in Italy.
    Coppola N; Alessio L; De Pascalis S; Macera M; Di Caprio G; Messina V; Onorato L; Minichini C; Stanzione M; Stornaiuolo G; Starace M; Monari C; Calò F; Sagnelli C; Pisaturo M
    Infect Dis Poverty; 2024 May; 13(1):39. PubMed ID: 38802954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Micro-elimination of hepatitis C through testing of Egyptian pregnant women presenting at delivery: implications for screening policies.
    Mostafa A; Ebeid FSE; Khaled B; Ahmed RHM; El-Sayed MH
    Trop Med Int Health; 2020 Jul; 25(7):850-860. PubMed ID: 32306545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C virus infection in jail: Difficult-to-reach, not to-treat. Results of a point-of-care screening and treatment program.
    Masarone M; Caruso R; Aglitti A; Izzo C; De Matteis G; Attianese MR; Pagano AM; Persico M
    Dig Liver Dis; 2020 May; 52(5):541-546. PubMed ID: 32234417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Hepatitis C Screening and Treatment Among Psychiatry Inpatients.
    Mandel E; Biondi MJ; Mendlowitz A; Maheandiran M; Hollingdrake E; Vanderhoff A; Wolfson-Stofko B; Capraru C; Feld JJ; Logan R
    J Clin Psychiatry; 2023 Jul; 84(5):. PubMed ID: 37530609
    [No Abstract]   [Full Text] [Related]  

  • 8. Emergency department targeted screening for hepatitis C does not improve linkage to care.
    Houri I; Horowitz N; Katchman H; Weksler Y; Miller O; Deutsch L; Shibolet O
    World J Gastroenterol; 2020 Aug; 26(32):4878-4888. PubMed ID: 32921964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in inpatient and outpatient hepatitis C virus prevalence and linkage to care rates in a safety net hospital hepatitis C screening program.
    Veeramachaneni H; Park B; Blakely D; Palacio A; Darby R; Fluker SA; Lyles RH; Miller LS
    J Gastroenterol Hepatol; 2021 Aug; 36(8):2285-2291. PubMed ID: 33724551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis virus (HCV) diagnosis and access to treatment in a UK cohort.
    Adland E; Jesuthasan G; Downs L; Wharton V; Wilde G; McNaughton AL; Collier J; Barnes E; Klenerman P; Andersson M; Jeffery K; Matthews PC
    BMC Infect Dis; 2018 Sep; 18(1):461. PubMed ID: 30217169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implementation of HCV screening in the 1969-1989 birth-cohort undergoing COVID-19 vaccination.
    D'Ambrosio R; Rizzardini G; Puoti M; Fagiuoli S; Anolli MP; Gabiati C; D'Amico F; Pasulo L; Restelli U; Colombo M; Lampertico P
    Liver Int; 2022 May; 42(5):1012-1016. PubMed ID: 35220667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver health events: an indigenous community-led model to enhance HCV screening and linkage to care.
    Pandey M; Konrad S; Reed N; Ahenakew V; Isbister P; Isbister T; Gallagher L; Campbell T; Skinner S
    Health Promot Int; 2022 Feb; 37(1):. PubMed ID: 34125199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C virus infection and risk of liver-related and non-liver-related deaths: a population-based cohort study in Naples, southern Italy.
    Piselli P; Serraino D; Fusco M; Girardi E; Pirozzi A; Toffolutti F; Cimaglia C; Taborelli M;
    BMC Infect Dis; 2021 Jul; 21(1):667. PubMed ID: 34238231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C screening and linkage to care with a mobile clinic in Southern Denmark.
    Dröse S; Øvrehus ALH; Holm DK; Røge BT; Christensen PB
    Int J Drug Policy; 2023 Nov; 121():104180. PubMed ID: 37714009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HCV testing and treatment initiation in an Italian prison setting: A step-by-step model to micro-eliminate hepatitis C.
    Fiore V; De Matteis G; Ranieri R; Saderi L; Pontali E; Muredda A; Ialungo AM; Caruso R; Madeddu G; Sotgiu G; Babudieri S
    Int J Drug Policy; 2021 Apr; 90():103055. PubMed ID: 33310637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hospital-based screening outperforms primary care screening as a means of achieving hepatitis C virus micro-elimination.
    Fernández-García CE; Gallego-Galiana J; Solís-Muñoz PA; Del Pozo-Maroto E; Domínguez-Alcón L; Tobar-Izquierdo M; Sáez A; Rodríguez de Cía J; Magaña-Sánchez A; Real-Martínez Y; García-Buey L; González-Moreno L; Caldas-Álvarez M; Cardeñoso-Domingo LM; González-Gamarra A; Salvador-Calvo A; González-Rodríguez Á; García-Monzón C
    Infect Dis Now; 2024 Mar; 54(2):104855. PubMed ID: 38309646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pragmatic Experience with Risk-based versus Universal Hepatitis C Screening in Pregnancy: Detection of Infection and Postpartum Linkage to Care.
    Bushman ET; Subramani L; Sanjanwala A; Dionne-Odom J; Franco R; Owen J; Subramaniam A
    Am J Perinatol; 2021 Sep; 38(11):1109-1116. PubMed ID: 33934324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis of the factors influencing the elimination strategies with the current status of diagnosis and treatment of hepatitis C in hospital].
    He N; Hao S; Feng G; Gao J; Kong FJ; Ren ZX; Xu MQ; Yang YQ
    Zhonghua Gan Zang Bing Za Zhi; 2021 Nov; 29(11):1053-1058. PubMed ID: 34933422
    [No Abstract]   [Full Text] [Related]  

  • 19. Progress and challenges of a pioneering hepatitis C elimination program in the country of Georgia.
    Averhoff F; Shadaker S; Gamkrelidze A; Kuchuloria T; Gvinjilia L; Getia V; Sergeenko D; Butsashvili M; Tsertsvadze T; Sharvadze L; Zarkua J; Skaggs B; Nasrullah M
    J Hepatol; 2020 Apr; 72(4):680-687. PubMed ID: 31811882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emergency department testing is feasible but ineffective to eliminate hepatitis C in Denmark.
    Wentworth JJ; Øvrehus ALH; Hansen JF; Biesenbach P; Christensen PB
    Infect Dis (Lond); 2021; 53(12):930-941. PubMed ID: 34379569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.